بدائل البحث:
greatest decrease » treatment decreased (توسيع البحث), greater increase (توسيع البحث)
greater decrease » greater increase (توسيع البحث), greater disease (توسيع البحث), rate decreased (توسيع البحث)
greatest decrease » treatment decreased (توسيع البحث), greater increase (توسيع البحث)
greater decrease » greater increase (توسيع البحث), greater disease (توسيع البحث), rate decreased (توسيع البحث)
-
1481
-
1482
-
1483
-
1484
-
1485
-
1486
Descriptive statistics.
منشور في 2025"…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …"
-
1487
Variable description.
منشور في 2025"…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …"
-
1488
Village characteristics.
منشور في 2025"…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …"
-
1489
Research data 2.
منشور في 2025"…The analysis reveals that the SHRR program significantly reduces travel frequency, likely due to improved local accessibility that decreases the need for frequent trips. …"
-
1490
-
1491
-
1492
-
1493
-
1494
-
1495
-
1496
-
1497
Baseline characteristics of the study sample<sup>β</sup>μ.
منشور في 2024"…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"
-
1498
The flow diagram of the study (CONSORT, 2010).
منشور في 2024"…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"
-
1499
-
1500